Procaps Group S.A. (PROC)
- Previous Close
2.6000 - Open
2.6500 - Bid 2.6100 x 100
- Ask 2.9700 x 100
- Day's Range
2.7271 - 2.7271 - 52 Week Range
1.9500 - 4.9500 - Volume
33 - Avg. Volume
12,280 - Market Cap (intraday)
307.682M - Beta (5Y Monthly) 0.13
- PE Ratio (TTM)
5.35 - EPS (TTM)
0.5100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
4.75
Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital use, such as antibiotic, blood clot, personal protective equipment, immunosuppressant, oncology, and analgesics products. In addition, the company offers over-the-counter (OTC) consumer healthcare products through a portfolio on approximately eight therapeutic areas, including gastrointestinal, skin care, cough and cold, analgesics, urological, vitamins, minerals, and supplements in the categories of antibiotics, anti-infective, anti-parasitic, cardiovascular, feminine care, cutaneous antimycotic, pain killers, gastro intestinal, hormonals, metabolic, endocrine, nervous system, ophthalmic, osteoarticular, respiratory, diet supplements, and vitamins and minerals. Further, it provides blood glucose meters, telemonitoring products, oral anti-diabetics products, cosmeceuticals, insulin delivery systems, and other diabetes solutions; and contract drug development and manufacturing services to third party pharmaceutical companies, specializing in soft gelatin capsule technologies. The company was founded in 1977 and is based in Luxembourg, Luxembourg.
www.procapsgroup.com5,500
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: PROC
Performance Overview: PROC
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PROC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PROC
Valuation Measures
Market Cap
307.68M
Enterprise Value
571.77M
Trailing P/E
5.35
Forward P/E
16.05
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.67
Price/Book (mrq)
7.81
Enterprise Value/Revenue
1.38
Enterprise Value/EBITDA
4.63
Financial Highlights
Profitability and Income Statement
Profit Margin
12.61%
Return on Assets (ttm)
6.28%
Return on Equity (ttm)
373.70%
Revenue (ttm)
414.1M
Net Income Avi to Common (ttm)
52.2M
Diluted EPS (ttm)
0.5100
Balance Sheet and Cash Flow
Total Cash (mrq)
17.56M
Total Debt/Equity (mrq)
753.94%
Levered Free Cash Flow (ttm)
-12.18M